Zhang, Ling
Zhao, Jing
Peng, Zhou
Zhang, Zhongxiao
Huang, Shan
Dong, Xiaohua
Gao, Jianfang
Guo, Xirong http://orcid.org/0000-0003-4873-8832
Funding for this research was provided by:
National Key Research and Development Program (2021YFC2701900, 2021YFC2701903)
National Natural Science Foundation of China (No.82170869, No.82100915)
Science and Technology Innovation Plan Of Shanghai Science and Technology Commission (No.22ZR1457000)
Master and Doctor innovation talent base for endocrine and metabolic diseases (RCJD2021S03)
Article History
Received: 28 April 2023
Accepted: 7 February 2024
First Online: 10 April 2024
Declarations
:
: The authors report no conflict of interest.
: The study involving human participants was approved by the Medical Ethics Committee of Shanghai Tongren Hospital of China (approval No. 2021-059-01). The patients/participants provided their written informed consent to participate in this study. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013).The experimental procedures of animal were approved by the Medical Ethics Committee of Shanghai Tongren Hospital of China (approval No. A2022-017-01). All experiments were performed in accordance with ARRIVE guidelines and regulations.
: All persons gave their informed consent prior to their inclusion in the study.